Staar Surgical Co. (NASDAQ:STAA)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 0.79. At the close of trading, the stock’s price was $46.39, to imply a decrease of -0.81% or -$0.38 in intraday trading. The STAA share’s 52-week high remains $73.13, putting it -57.64% down since that peak but still an impressive 42.53% since price per share fell to its 52-week low of $26.66. The company has a valuation of $2.27B, with an average of 727.37K shares over the past 3 months.
Staar Surgical Co. (NASDAQ:STAA) trade information
After registering a -0.81% downside in the last session, Staar Surgical Co. (STAA) has traded red over the past five days. The stock hit a weekly high of 50.00, dropping -0.81% in its intraday price action. The 5-day price performance for the stock is -6.83%, and 17.12% over 30 days. With these gigs, the year-to-date price performance is 48.64%.
Staar Surgical Co. (STAA) estimates and forecasts
Looking at statistics comparing Staar Surgical Co. share performance against respective industry, we note that the company has underperformed competitors. Staar Surgical Co. (STAA) shares are 8.92% up over the last 6 months, with its year-to-date growth rate lower than industry average at -48.70% against 7.50%. Revenue is forecast to shrink -77.80% this quarter before falling -40.00% for the next one. The rating firms project that company’s revenue will grow 5.00% compared to the previous financial year.
Revenue forecast for the current quarter as set by 11 analysts is $74.91 million. Meanwhile, for the quarter ending Jun 2024, a total of 11 analyst(s) estimate revenue growth to $95.33 million.Earnings reports from the last fiscal year show that sales brought in $66.96 million and $92.31 million respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 11.90% before jumping 3.30% in the following quarter.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 31.51% for the past 5-year period. While 2024 is set for a -39.64% return in earnings, projections for the next 5 years are at 30.00% annually.
STAA Dividends
Staar Surgical Co. has its next earnings report out in May. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too. Staar Surgical Co. has a forward dividend ratio of 0, with the share yield ticking at 0.00% to continue the rising pattern observed over the past year. The company’s average dividend yield trailing the past 5-year period is 0.00%.
